US Pharma MarketingPSG report examines payers and employers’ attitudes towards GLP-1 coverage, unbundling’ PBM models
PSG report examines payers and employers’ attitudes towards GLP-1 coverage, unbundling’ PBM models is a pharma and life sciences industry update from Fierce Healthcare. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
The annual drug benefit design report drew insights from 237 benefits leaders across employers, health plans and unions.
Source: Fierce Healthcare